IP Library › Granted Patent US 8,518,260
Granted Patent B2
US 8,518,260 · App. 12/896,009 · Granted Aug 27, 2013

Method of controlling diffusive sodium transport in dialysis

Inventors: Jochen G. Raimann (New York, NY); Erik Lars Penne (Amsterdam, NL); Stephan Thijssen (New York, NY); Peter Kotanko (New York, NY); Nathan W. Levin (New York, NY)
Assignee: Fresenius Medical Care Holdings, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,518,260
App. No.
12/896,009
Granted
Aug 27, 2013
Kind
B2
Abstract

A method of controlling diffusive sodium transport from the dialysate solution to the blood of a patient undergoing hemodialysis treatment or from the blood to the dialysate solution includes calculating SNa + average , an average of the patient's historic serum sodium concentrations, and estimating SNa + estimated , the patient's pre-dialysis serum sodium concentration, based on the average of the patient's measured historic pre-dialysis serum sodium concentrations, SNa + measured . The method enables adjusting DNa + , the sodium concentration of the dialysate solution, based on the average of the patient's historic serum sodium concentrations, SNa + average , if needed, and performing the dialysis treatment of the patient using a dialysate solution containing a sodium concentration DNa + .

Claims (8)

1. A method of controlling diffusive sodium transport from dialysate solution to blood of a patient undergoing hemodialysis treatment or from blood into the dialysate solution comprising:

a) calculating SNa + average , an average of the patient's measured historic serum sodium concentrations, SNa + measured ;

b) estimating SNa + estimated , the patient's pre-dialysis serum sodium concentration, based on the average, SNa + average , of the patient's pre-dialysis serum sodium concentrations over a historic time interval of at least 4 months;

c) determining GNa+, a desired gradient between SNa + estimated and DNa + , the sodium concentration in a dialysate solution; and

d) performing the dialysis treatment of the patient using the dialysate solution containing the sodium concentration DNa + based upon SNa + estimated .

2. The method of claim 1 , wherein the patient's historic serum sodium concentrations include corrections for void volume and Gibbs-Donnan effect.

3. The method of claim 1 , wherein DNa + =SNa + estimated .

4. The method of claim 2 , wherein DNa + =SNa + estimated .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2012
From: RAIMANN, JOCHEN G.; PENNE, ERIK LARS; THIJSSEN, STEPHAN; KOTANKO, PETER; LEVIN, NATHAN W.
To: FRESENIUS MEDICAL CARE HOLDINGS, INC.
Reel/Frame 027753/0423 →
Continuity (2)
Provisional Application 61277957 · Oct 1, 2009
Related Publication 20110079558A1 · Apr 7, 2011